ALZN
ALZAMEND (ALZN)
NASDAQ
$1.29-$0.02 (-1.22%)
Price as of Aug 03, 2026 7:31 AM EDT
  • $6.3M
    Market Cap
  • -40.45%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
04/30/2026
04/30/2025
04/30/2024
04/30/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-3.6M
+156.53%
-1.4M
-78.08%
-6.5M
-13.31%
-7.4M
+43.15%
Depreciation and Amortization Expense
110,740
+118.25%
50,740
0.00%
50,740
+119.98%
23,066
+549.93%
Total Operating Expenses
8.8M
+94.96%
4.5M
-54.75%
9.9M
-33.17%
14.9M
+20.71%
Operating Profit
-8.8M
+94.96%
-4.5M
-54.75%
-9.9M
-33.17%
-14.9M
+20.71%
Interest Income
1,078
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-6,619
-63.29%
-18,029
+78.49%
-10,101
+31.16%
-7,701
-83.45%
Interest Income and Expense and Net
-5,541
-69.27%
-18,029
+78.49%
-10,101
+31.16%
-7,701
-83.45%
Total Nonoperating Income and Expense
-5,541
-69.27%
-18,029
+78.49%
-10,101
+31.16%
-7,701
-81.89%
Income before Taxes
-8.8M
+71.84%
-5.1M
-48.63%
-9.9M
-33.17%
-14.9M
+20.71%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.8M
+71.84%
-5.1M
-48.68%
-9.9M
-33.14%
-14.9M
+20.35%
Net Income from Continuing Operations Applicable to Common
-8.8M
+71.84%
-5.1M
-48.68%
-9.9M
-33.14%
-14.9M
+20.35%
Basic EPS and Net Income
-2.63
-76.77%
-11.32
-22.99%
-14.70
+9,700.00%
-0.15
N/A
Diluted EPS and Net Income
-2.63
-76.77%
-11.32
-22.99%
-14.70
+9,700.00%
-0.15
N/A
Basic Weighted Average Shares
3.3M
+640.27%
450,799
-33.37%
676,565
-99.31%
97.5M
+9.45%
Diluted Weighted Average Shares
3.3M
+640.27%
450,799
-33.37%
676,565
-99.31%
97.5M
+9.45%
Balance Sheet
Cash and Cash Equivalents
710,689
-82.00%
3.9M
+950.04%
376,048
-92.69%
5.1M
-63.45%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
710,689
-82.00%
3.9M
+950.04%
376,048
-92.69%
5.1M
-63.45%
Total Current Assets
1.8M
-57.76%
4.2M
+817.62%
455,242
-92.20%
5.8M
-59.51%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
314,866
-26.02%
425,606
+141.35%
176,346
+120.87%
79,843
-22.41%
Total Long-Term Assets
314,866
-26.02%
425,606
+141.35%
176,346
+120.87%
79,843
-22.41%
Total Assets
2.1M
-54.83%
4.6M
+628.80%
631,588
-89.32%
5.9M
-59.25%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
300,714
N/A
N/A
N/A
Total Current Liabilities
1.3M
+112.07%
634,761
-80.32%
3.2M
+12.39%
2.9M
+146.38%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.3M
+112.07%
634,761
-80.32%
3.2M
+12.39%
2.9M
+146.38%
Retained Earnings
-67.3M
+14.99%
-58.5M
+8.36%
-54.0M
+22.57%
-44.1M
+50.96%
Total Stockholders Equity
733,211
-81.52%
4.0M
+252.97%
-2.6M
-185.18%
3.0M
-77.19%
Total Shares Outstanding
4.3M
+446.53%
778,733
+13.19%
687,999
-99.29%
96.9M
+1.53%
Cash Flow
Cash from Operating Activities
-8.1M
+22.83%
-6.6M
-20.58%
-8.3M
-7.32%
-8.9M
+34.91%
Capital Expenditures
N/A
N/A
300,000
+103.74%
147,243
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
-300,000
+103.74%
-147,243
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.8M
-53.74%
10.4M
+185.86%
3.7M
+1,826,112.50%
200
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-262.55%
+34.61%
-195.05%
-35.81%
-303.88%
+108.66%
-145.64%
+2.66%
Return on Equity
-373.18%
-49.78%
-743.08%
-83.14%
-4,408.31%
+2,329.17%
-181.47%
+12.77%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.31
-80.08%
6.58
+4,564.07%
0.14
-93.06%
2.03
-83.57%
Cash Ratio
0.53
-91.51%
6.22
+5,235.08%
0.12
-93.49%
1.79
-85.16%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow